Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 3, 2010, Pages 219-225

  Saad, Reda S ^a   Liu, Yulin L ^a   Silverman, Jan F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Basal cell markers; Bronchioloalveolar carcinoma; K903; P63

Indexed keywords

CYTOKERATIN ANTIBODY; K903 ANTIBODY; MYOSIN; PROTEIN P63; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL CARCINOMA; LUNG LESION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE MYOSINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951702968     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181c6feec     Document Type: Article

References (30)

1. Black RJ, Bray F, Ferlay J, et al. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33:105-107.
2. Travis WD, Lubin J, Ries L, et al. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer. 1996;77:2464-2470.
3. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354:99-105.
4. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low dose spiral CT versus radiography. Radiology. 1996;201:798-802.
5. Kaneko M, Kusumoto M, Kobayashi T, et al. Computed tomography screening for lung carcinoma in Japan. Cancer. 2000;89: 2485-2488.
6. Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351: 1242-1245.
7. Sarantopoulos GP, Gui D, Shintaku P, et al. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. Arch Pathol Lab Med. 2004;128:406-414.
8. Barkley JE, Green MR. Bronchioloalveolar carcinoma. J Clin Oncol. 1996;14:2377-2386.
9. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components. Clinicopathological features, subclassification by extent of invasive foci and immunohistochemical characterization. Am J Surg Pathol. 2003; 27:937-951.
10. Higashiyama M, Kodama K, Yokouchi H, et al. Prognsotic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg. 1999;68:2069-2073.
11. Yamashiro K, Yasuda S, Nagase A, et al. Prognostic significance of an interface pattern of central fibrosis and tumor cells in peripheral adenocarcinoma of the lung. Hum Pathol. 1995;26:67-73.
12. Clayton F. Bronchioloalveolar carcinomas: cell types, patterns of growth and prognostic correlates. Cancer. 1986;57:1555-1564.
13. Brambilla E, Travis WD, Colby TV, et al. The new World Health organization classification of lung tumors. Eur Respir J. 2001;18: 1059-1068.
14. Franklin WA. Diagnosis of lung caner: pathology of invasive and preinvasive neoplasia. Chest. 2000;117(suppl 1):80S-89S.
15. Colby TV. Malignancies in the lung and pleura mimicking benign processes. Semin Diagn Pathol. 1995;12:30-44.
16. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cellspecific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161-1168.
17. Ramnani DM, Bostwick DG. Basal cell-specific anti-keratin antibody 34betaE12: optimizing its use in distinguishing benign prostate and cancer. Mod Pathol. 1999;12:443-444.
18. Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34betaE12p63) improves the detection of prostate basal cells. Am J Surg Pathol. 2003;27:365-371.
19. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol. 2002;15:1302-1308.
20. Kalof AN, Tam D, Beatty B, et al. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain. J Clin Pathol. 2004;57:625-629.
21. Pelosi G, Pasini F, Olsen Stenholm C, et al. P63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol. 2002;198:100-109.
22. Wang BY, Gil J, Kaufman D, et al. P63 in pulmonary epithelium, pulmonary squamous cell neoplasms, and other pulmonary tumors. Hum Pathol. 2002;33:921-926.
23. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant negative activities. Mol Cell. 1998;2:305-316.
24. Au NH, Gown AM, Cheang M, et al. p63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol. 2004;12:240-247.
25. Sheikh HA, Fuhrer K, Cieply K, et al. p63 expression in assessment of bronchioloalveolar proliferations of the lung. Mod Pathol. 2004; 17:1134-1140.
26. Wu M, Orta L, Gil J, et al. Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma. Mod Pathol. 2008;21:553-558.
27. Roggli VL, Vollmer RT, Greenberg SD, et al. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol. 1985;16:569-579.
28. Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer. 2000;83:632-636.
29. Takasmochi K, Ogura T, Suzuki K, et al. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol. 2001; 159:1941-1948.
30. Westra WH. Early glandular neoplasia of the lung. Respir Res. 2000; 1:163-169.